CMS announces payment changes for skilled nursing, hospice, rehab facilities

In a flurry of announcements July 28, CMS released its payment and policy changes for three Medicare payment systems in fiscal year 2017: skilled nursing facilitieshospice benefit and inpatient rehabilitation facilities.

Skilled nursing facilities

  • Projects payment increase of $920 million, or 2.4 percent.
  • Changes to quality reporting program, with new quality measures for payment determination beginning in 2018: Medicare spending per beneficiary, discharge to community, and potentially preventable 30-day post-discharge readmission.
  • A separate quality measure beginning in 2020 for medication reconciliation, titled “Drug Regimen Review Conducted with Follow-Up for Identified Issues."
  • A final rule on the value-based purchasing program for skilled nursing facilities, which will begin in fiscal year 2019.

Medicare hospice benefit

  • Projects payment increase of $350 million, or 2.1 percent.
  • Final rule on the experience of care survey, including requiring hospices to collect survey data on ongoing basis in 2017 for 2019 payment update.
  • Finalizes new quality measures for 2017, titled “Hospice Visits When Death is Imminent” and “Hospice and Palliative Care Composite Process Measure.”
  • Public reporting of hospice data to begin via compare site in 2017.

Inpatient rehabilitation facilities

  • Projects payment increase of $14 million, or 1.9 percent.
  • No changes to facility-level adjustment.
  • Continues phasing out of rural adjustment.
  • Final rule adopts three quality measures on resource use for fiscal year 2018: Medicare spending per beneficiary, discharge to community, and potentially preventable 30-day post-discharge readmission.
  • Adopts new quality measure on medication reconciliation for fiscal year 2020 titled “Drug Regimen Review Conducted with Follow-Up for Identified Issues."
  • Public reporting of IRF data will begin in fall 2016.
""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.